Skip to main content

Asthma Inhalers Tied to Large Greenhouse Gas Emissions Production

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 4, 2024.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Sept. 4, 2024 -- Inhaler devices are a substantial source of greenhouse gas emissions in the United States, according to a research letter published online Aug. 29 in the Journal of the American Medical Association.

Jyothi Tirumalasetty, M.D., from the Stanford University School of Medicine in California, and colleagues assessed mean emissions in 2022 for U.S. brand-name inhalers (metered-dose, dry powder, and soft-mist classes) prescribed to Medicare Part D and Medicaid beneficiaries using inhaler claims and cost data extracted from the Centers for Medicare & Medicaid Services (CMS) summary and statistics database.

The researchers found that mean estimated emissions per inhaler by device class were 23.1 kg of carbon dioxide equivalent (CO2e) for metered-dose inhalers (14 inhalers), 0.79 kg CO2e for dry-powder inhalers (19 inhalers), and 0.78 kg CO2e for soft-mist inhalers (4 inhalers), with 10 kg CO2e equivalent to 41.2 km driven in an average gasoline-powered passenger vehicle. The highest emissions per inhaler were seen for the inhaled corticosteroid, long-acting β-agonist, metered-dose inhaler Dulera (mometasone/formoterol; 48.1 kg CO2e) versus an analogous inhaled corticosteroid, long-acting β-agonist, dry-powder inhaler Advair Diskus (fluticasone/salmeterol; 0.898 kg CO2e emissions per inhaler). For short-acting β-agonist medications, Ventolin HFA (albuterol sulfate) had the highest emissions (28.7 kg CO2e per inhaler). Overall, there were 69.8 million CMS inhaler claims in 2022, resulting in an estimated 1.15 million metric tons of CO2e emissions, or the equivalent of 226,960 homes' yearly electricity use.

"Formulary choices that optimize clinical efficacy, greenhouse gas emissions, and affordability may improve patient outcomes and reduce climate pollution," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Methotrexate Noninferior to Prednisone in Pulmonary Sarcoidosis

TUESDAY, May 20, 2025 -- For patients with pulmonary sarcoidosis, methotrexate is noninferior to prednisone with regard to the change from baseline to week 24 in the percentage of...

Use of Composite Allocation Score for Lung Transplant Wait List Improves Outcomes

MONDAY, May 19, 2025 -- Wait-list outcomes for lung transplants have substantially improved in the composite allocation score (CAS) era, according to a study presented at the...

Asthma Attacks Increase for Some Women Taking Progestogen-Only Pill

THURSDAY, May 8, 2025 -- Use of a combined oral contraceptive (COC) is not associated with asthma in women of reproductive age, but use of a progestogen-only pill (POP) is...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.